期刊文献+

食管鳞癌中微小RNA miR-200c的表达及其意义 被引量:6

Expression of MiR-200c in esophageal squamous cell cancer and its clinical significance
暂未订购
导出
摘要 目的检测食管鳞癌中微小RNA miR-200c的表达,探讨其与肿瘤发展和分期的关系。方法应用实时荧光定量PCR方法检测76例各类分期分型食管鳞癌和配对癌旁组织中miR-200c的表达,分析其表达与肿瘤临床分期和病理分型的关系。结果食管鳞癌组织与癌旁组织比较,miR-200c的表达显著减少(P<0.01);miR-200c的表达在中晚期(III、IV期)食管鳞癌组织较早中期(Ⅰ、Ⅱ)食管鳞癌组织降低更为显著(P<0.01)。结论 miR-200c在食管鳞癌发生发展过程中表达有明显降低,其表达水平可作为潜在的食管鳞癌临床分期分级和预后的指标。 【Objective】 To examine the miR-200c expression in esophageal squamous cell cancer(ESCC) and correlate it with patient clinical status.【Methods】 Expression levels of miR-200c were quantitated with stem-loop quantitative reverse transcription-PCR in 76 ESCC patients and paired normal controls.The obtained results were correlated to the pathoclinical status and metastasis of the patients.【Results】 ①Expression levels of miR-200c were over-expressed in ESCC tissues compared with normal controls(P 〈0.001).② Statistics analysis showed that miR-200c was more amplified in advanced and low differentiated ESCCs(P 〈0.01).【Conclusion】 Amplification of miR-200c is frequent in ESCCs and is correlated with tumor progression.The expression level of miR-200c may be used as a potential biomarker of ESCC progression.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2012年第19期42-45,共4页 China Journal of Modern Medicine
基金 深圳市科技计划项目(No:201102164)
关键词 食管鳞癌 微小RNA MIR-200C 关联分析 esophageal squamous cell cancer microRNA miR-200c correlation analysis
  • 相关文献

参考文献3

二级参考文献33

  • 1Cameron M Smith,David I Watson,Michael Z Michael,Damian J Hussey.MicroRNAs, development of Barrett’s esophagus, and progression to esophageal adenocarcinoma[J].World Journal of Gastroenterology,2010,16(5):531-537. 被引量:23
  • 2Cunningham D,Allum WH,Stenning SP,菅鑫妍.手术期间化学疗法与单独手术治疗可切除的胃食管癌疗效比较[J].中国处方药,2006,5(8):59-60. 被引量:434
  • 3Shu-Lian Wang,Zhongxing Liao,Helen Liu(,Jaffer Ajani,Stephen Swisher,James D Cox,Ritsuko Komaki.Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer[J].World Journal of Gastroenterology,2006,12(34):5501-5508. 被引量:27
  • 4Roush SF, Slack FJ. Micromanagement: a role for microRNAs in mRNA stability. ACS Chem Biol 2006; 1:132-134.
  • 5Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Mallet B, Hayward DC, Ball EE, Degnan B, MOiler P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000; 408:86-89.
  • 6Rajewsky N. microRNA target predictions in animals. Nat Genet 2006; 38 Suppl: S8-S13.
  • 7Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006; 94:776-780.
  • 8Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101:2999-3004.
  • 9Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-714.
  • 10Tricoli JV, Jacobson JW. MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis. Cancer Res 2007; 67: 4553-4555.

共引文献50

同被引文献67

  • 1谭国斌,邱明宁,陈合格,柳建军.miR-200c与肿瘤进展关系的研究进展[J].中国肿瘤生物治疗杂志,2015,22(1):120-124. 被引量:3
  • 2Sourbier C. Ovarian cancer: emerging molecular-targeted thera- pies[J]. Biologics, 2012,6 : 147-154.
  • 3Kuhlmann JD, Raseh J, Wimberger P, et al. microRNA and the pathogenesis of ovarian cancer--a new horizon for molecular di- agnostics and treatment? [J]. Clin Chem Lab Med, 2012,50 (4) : 601-615.
  • 4Hu X, Macdonald DM, Huettner PC,et al. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer[J]. Gynecol Oncol, 2009,114(3) : 457-464.
  • 5Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIPI[J]. Nat Rev Cancer,2008,10(5):593- 601.
  • 6Park SM,Gaur AB, Lengyel E, et al. The miR-200 family deter- mines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 [J]. Genes Dev, 2008,22 (7) :894-907.
  • 7Chen D,Zhang Y,Wang J,et al. MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117 + CD44 + ovarian cancer stem cells by regulating epithelial-mesenchymal transition [J]. J Ovarian Res,2013,6(1) :50-56.
  • 8Gregory PA,Bracken CP, Bert AG, et al. MicroRNAs as regula- tors of epithelial-mesenchymal transition[J]. Cell Cycle, 2008,7 (20) :3112-3118.
  • 9Korpal M,Lee ES, Hu G,et al. The miR-200 family inhibits epi- thelial-mesenchymal transition and cancer cell migration by direct targeting of E-eadherin transcriptional repressors ZEB1 and ZEB2[J]. J Biol Chem,2008,283(22) :14910-14914.
  • 10Uhlmann S,Zhang JD,Schwager A. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer[J].{H}ONCOGENE,2010,(30):4297-4306.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部